We are a specialty medical device company dedicated to bringing vision and freedom back to patients suffering from late-stage conditions of the retina. We are engaged in the research, development, manufacturing and marketing of proprietary ophthalmic devices and technologies that are intended to significantly improve the vision and quality of life of individuals with untreatable […]

(Note: FGI Industries Ltd. priced its unit IPO on Jan. 24, 2022, at $6 – the bottom of its $6-to-$8 range – on 2.5 million units (stock and warrants). Background: FGI Industries had revised the IPO’s structure on Jan. 18, 2022, to a unit offering consisting of 2.5 million units at $6 to $8 each […]

We intend to focus our search on targets operating in the technology-focused areas, including software, mobile and Internet of Things (“IoT”) applications, digital and energy transformation, cloud and cyber communications as well as high bandwidth services, including LTE, remote sensing and 5G communications. (Note: Industrial Tech Acquisitions II, Inc. priced its SPAC IPO on Jan. 11, […]

Hillstream BioPharma is a pre-clinical biotech company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (“IMCD”) for treatment-resistant cancers. Our most advanced product candidate is HSB-1216, an IMCD inducer, targeting a variety of solid tumors. In a clinical pilot study conducted in Germany by the University […]

We are an online retailer of home goods, toys, apparel and consumer electronics. We operate as a wholesaler on Amazon. We generate most of our revenue as a third-party seller on Amazon (www.amazon.com). In late 2020, the company expanded to offer goods online at Walmart (www.walmart.com). We also sell merchandise on our own website: www.hourloop.com. […]

We intend to focus on businesses that have their primary operations located in North America and Europe in the neuro-musculoskeletal industry. Our sponsor is an affiliate of Viscogliosi Brothers, LLC (“VB”), a single-family office founded by Anthony, John, and Marc Viscogliosi, with extensive experience in the neuro-musculoskeletal (“NMS”) industry. VB has invested in more than […]

We intend to focus on businesses at the leading edge of innovation in national security in these three key sectors: space, cybersecurity and energy transition. (Note: C5 Acquisition Corp. priced its SPAC IPO on Jan. 6, 2022, in line with the terms in its prospectus: 25 million units at $10 each to raise $250 million.)

We intend to focus on the media and entertainment sectors. (Blank check company incorporated in the Cayman Islands) Our management team has extensive experience with blank check companies, also known as special-purpose acquisition companies (SPACs), going back to 2011, with the following eight SPACs: Spinning Eagle, Soaring Eagle, Flying Eagle, Diamond Eagle, Platinum Eagle, Double […]

(Note: Affinia Therapeutics, Inc. withdrew its IPO plans in an SEC filing dated Dec. 2, 2022. The S-1 was filed on Jan. 4, 2022. No terms were filed, although estimated IPO proceeds were $100 million.) We are a preclinical stage company pioneering a new class of rationally designed gene therapies with potentially curative benefit in […]

We currently intend to focus our efforts on identifying high growth technology and tech-enabled businesses domestically and abroad in the consumer Internet, ecommerce, software, healthcare, transportation / mobility and financial services industries, as well as other industries that are being disrupted by advances in technology and on technology paradigms, including artificial intelligence (“AI”), automation, data […]